Literature DB >> 19921100

Prevalence, clinical correlates and treatment of permanent atrial fibrillation among the elderly: insights from the first prospective population-based study in rural Greece.

Ilias Ninios1, Harilaos Bogossian, Markus Zarse, Fotini Lazaridou, Kyriakos Dimitriadis, Vlasios Ninios, Bernd Lemke, George Louridas.   

Abstract

To investigate the prevalence of permanent atrial fibrillation (AF), its clinical associated conditions and treatment status in the elderly population in rural Greece. 720 people (46.1% males) older than 65 years (mean age: 72.5 +/- 5.7 years) living in four villages in rural Greece were screened with an electrocardiogram (response rate: 90.5%) for the presence of permanent AF. They underwent a physical examination, including blood pressure (BP) measurement, and body mass index (BMI) calculation, in addition to an interview about their medical history, physical activity, smoking habits, alcohol consumption and medication use. Subjects with AF for whom anticoagulants were contraindicated were identified and stroke risk stratification was performed using the CHADS2 algorithm. The prevalence of permanent AF was 5% (6.6% among men and 3.6% among women) and it increased with age. In the entire population, ECG evidence of myocardial ischaemia and ventricular premature beats were independently associated with the presence of permanent AF (OR 5.266; 95% CI 2.22-12.49, P = 0.0001 and OR 2.61; 95% CI 1.059-6.432, P = 0.037, respectively), while female sex was independently associated with the absence of the AF (OR 0.327; CI 0.147-0.729, P = 0.006). From those patients who were eligible for anticoagulation, 40.6% were treated with anticoagulants, 34.3% were given antiplatelets therapy and the rest received no antithrombotic treatment. This is the first prospective study demonstrating the prevalence, clinical correlates and treatment status of permanent AF in Greece. These results confirm the high prevalence of permanent AF among the elderly and underscore the issue regarding anticoagulants underutilization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19921100     DOI: 10.1007/s11239-009-0422-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  29 in total

1.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

2.  The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems.

Authors:  Giuseppe Boriani; Igor Diemberger; Cristian Martignani; Mauro Biffi; Angelo Branzi
Journal:  Eur Heart J       Date:  2006-03-16       Impact factor: 29.983

3.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

Authors:  A Ott; M M Breteler; M C de Bruyne; F van Harskamp; D E Grobbee; A Hofman
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

4.  Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice.

Authors:  M Langenberg; B S Hellemons; J W van Ree; F Vermeer; J Lodder; H J Schouten; J A Knottnerus
Journal:  BMJ       Date:  1996-12-14

Review 5.  Recent progress in the epidemiology of atrial fibrillation.

Authors:  Robert T Greenlee; Humberto Vidaillet
Journal:  Curr Opin Cardiol       Date:  2005-01       Impact factor: 2.161

6.  Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002).

Authors:  Kamakshi Lakshminarayan; Craig A Solid; Allan J Collins; David C Anderson; Charles A Herzog
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

7.  Atrial fibrillation and antithrombotic treatment in Italian hospitalized patients: a prospective, observational study.

Authors:  W Ageno; F Ambrosini; B Nardo; D Imperiale; F Dentali; V Mera; R Cattaneo; E Barlocco; L Steidl; A Venco
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300

8.  Screening for atrial fibrillation in primary care.

Authors:  N M Wheeldon; D I Tayler; E Anagnostou; D Cook; C Wales; G D Oakley
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

9.  Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial.

Authors:  R Saxena; S Lewis; E Berge; P A Sandercock; P J Koudstaal
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

10.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study.

Authors:  S Stewart; C L Hart; D J Hole; J J McMurray
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

View more
  2 in total

Review 1.  Review of screening studies for atrial fibrillation in rural populations of 11 countries.

Authors:  Alex I Gavino; Craig S McLachlan
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

2.  Atrial Fibrillation in Hypertension: Patients' Characteristics.

Authors:  Styliani Koutsaki; Ioannis Koutelekos; Georgia Gerogianni; Maria Koutsaki; Aggeliki Koukouzeli; Georgia Fouka; Maria Polikandrioti
Journal:  Mater Sociomed       Date:  2018-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.